BDNF and neuroblastoma: Specifically, there is increasing evidence that the neurotrophic receptor tyrosine kinase TrkB, sometimes in conjunction with its primary ligand BDNF, is over-expressed in a variety of human cancers, ranging from neuroblastomas to pancreatic ductal adenocarcinomas [51–55].